Skip to content

Cysteine-Inspired Photosensitizer with Efficient Tumor Accumulation Enables Thermoresistance Reversal for Reciprocal Enhancement of Photodynamic-Photothermal Therapy.

Sep 2026 · ACS Applied Materials and Interfaces · 0 citations
Medicine

TL;DR

A cysteine-inspired conjugated polymer photosensitizer was developed to integrate enhanced tumor accumulation, hydrogen sulfide generation, photodynamic therapy (PDT), and photothermal therapy (PTT), achieving an 89% tumor inhibition rate without detectable skin injury or systemic toxicity.

Abstract

Abstract Insufficient tumor accumulation and heat shock protein (HSP)-mediated adaptive resistance remain major barriers to effective cancer therapy. Here, a cysteine-inspired conjugated polymer photosensitizer (CP-PCys) was developed to integrate enhanced tumor accumulation, hydrogen sulfide (H2S) generation, photodynamic therapy (PDT), and photothermal therapy (PTT). Dense cysteine functionalization promoted cellular uptake, resulting in approximately 2.4-fold higher accumulation in 4T1 cells than that of the polyethylene glycol-functionalized control after 24 h. Meanwhile, the conjugated backbone enabled NIR-II fluorescence imaging, a photothermal conversion efficiency of 52.3%, and efficient reactive oxygen species generation (58.6%). Intracellular H2S disrupted energy metabolism and suppressed HSP70 expression, while PDT-generated reactive oxygen species further reinforced this effect. Combined irradiation reduced HSP70 expression to approximately 57% of the PBS control level, thereby sensitizing tumor cells to PTT. Conversely, PTT-induced hyperthermia enhanced reactive oxygen species generation and potentiated PDT, aggravating mitochondrial dysfunction and DNA damage. In 4T1 tumor-bearing mice, CP-PCys rapidly accumulated in tumors and produced stable mild photothermal heating. Combined PDT–PTT achieved an 89% tumor inhibition rate without detectable skin injury or systemic toxicity, demonstrating the potential of CP-PCys for effective and atraumatic cancer phototherapy.

View source

Similar papers

Open access Sep 2026

Rational Design of Porphyrin-Based Nano-Prodrug for Overcoming ROS Resistance and Synergistic Photodynamic Cancer Therapy.

Porphyrin-based photosensitizers (PSs) are among the most widely explored agents for photodynamic therapy (PDT), yet their clinical translation is severely limited by poor biocompatibility, aggregation-induced quenching, insufficient tumor selectivity, and the intrinsic reactive oxygen species (ROS) resistance of cance...

Yi-Hui Ai, Chong-Zhi Wu, Zhi-Yao Li et al. · 0 citations
Sep 2026

Glutathione-Responsive Nano-Prodrug Mediates Synergistic Photothermal Chemotherapy for Tumor Inhibition.

Photothermal therapy (PTT) offers the advantages of noninvasiveness and high selectivity, while chemotherapy shows potent antitumor activity. However, their standalone applications are limited by insufficient photothermal ablation efficacy and chemotherapeutic resistance, respectively. To address these challenges, we d...

Yu Jiang, Chen Guo, Zhen-Kun Sun et al. · 0 citations
Open access Sep 2026

Self-Assembled Cationic Phthalocyanine Nanophotosensitizer Drives Hypoxia-Tolerant Photodynamic Immunotherapy for HCC

Background Photodynamic therapy (PDT) eliminates malignancies through spatially controlled reactive oxygen species (ROS) generation and has achieved clinical success in localized tumors. Nevertheless, its therapeutic potential is severely restricted by the poor aqueous solubility, suboptimal ROS generation efficiency,...

Fang-Cheng Jiang, Yue Qin, Li Gao et al. · 0 citations
Open access Aug 2026

A Dual GSH/ROS-Functional NIR Fluorescent Platform for Synergistic Photodynamic Therapy and Radiosensitization in Nasopharyngeal Carcinoma.

A theranostic platform HSF, featuring integrated tumor-specific near-infrared fluorescence imaging and photodynamic ROS generation for real time monitoring and targeted radiotherapy of solid malignancies for NPC, offering a transformative approach for real time visualization-guided NPC therapy.

Fan Zheng, Yan Mo, Jin Zhou et al. · 0 citations

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.